Comparison of infectious complications with BCMA-directed therapies in multiple myeloma

B-cell-maturation-antigen (BCMA)-directed therapies are highly active for multiple myeloma, but infections are emerging as a major challenge. In this retrospective, single-center analysis we evaluated infectious complications after BCMA-targeted chimeric-antigen-receptor T-cell therapy (CAR-T), bisp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood cancer journal (New York) Jg. 14; H. 1; S. 88 - 8
Hauptverfasser:	Nath, Karthik, Shekarkhand, Tala, Nemirovsky, David, Derkach, Andriy, Costa, Bruno Almeida, Nishimura, Noriko, Farzana, Tasmin, Rueda, Colin, Chung, David J., Landau, Heather J., Lahoud, Oscar B., Scordo, Michael, Shah, Gunjan L., Hassoun, Hani, Maclachlan, Kylee, Korde, Neha, Shah, Urvi A., Tan, Carlyn Rose, Hultcrantz, Malin, Giralt, Sergio A., Usmani, Saad Z., Shahid, Zainab, Mailankody, Sham, Lesokhin, Alexander M.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London Nature Publishing Group UK 31.05.2024 Springer Nature B.V Nature Publishing Group
Schlagworte:	692/699/255 692/699/67/1990/804 Adult Aged Aged, 80 and over Antibodies, Bispecific - adverse effects Antibodies, Bispecific - therapeutic use Antigens B-Cell Maturation Antigen - immunology Biomedical and Life Sciences Biomedicine Cancer Research Female Hematology Humans Immunoconjugates - adverse effects Immunoconjugates - therapeutic use Immunotherapy, Adoptive - adverse effects Incidence Infections Infections - epidemiology Infections - etiology Male Middle Aged Multiple myeloma Multiple Myeloma - therapy Neutropenia Oncology Retrospective Studies
ISSN:	2044-5385, 2044-5385
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!